Amarin Corporation plc [AMRN] is -61.13% lower this YTD. Is it still time to buy?

Amarin Corporation plc [NASDAQ: AMRN] price surged by 11.97 percent to reach at $0.14. The company report on November 7, 2022 that Amarin Highlights Key Data Presented at American Heart Association 2022 Scientific Sessions for VASCEPA®/VAZKEPA (icosapent ethyl) and Patient Care.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored


— Independent RESPECT-EPA Study Now Third in a Series of Trials to Underscore CV Risk Reduction Benefits of Eicosapentaenoic Acid for Patients –.

— PROMINENT Study Failed to Show CV Risk Reduction Benefit of the Fibrate Class for Statin-Treated High-Risk Patients –.

A sum of 8243102 shares traded at recent session while its average daily volume was at 3.14M shares. Amarin Corporation plc shares reached a high of $1.34 and dropped to a low of $1.175 until finishing in the latest session at $1.31.

The one-year AMRN stock forecast points to a potential upside of 60.66. The average equity rating for AMRN stock is currently 3.00, trading closer to a bullish pattern in the stock market.

Guru’s Opinion on Amarin Corporation plc [AMRN]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AMRN shares is $3.33 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AMRN stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

JP Morgan have made an estimate for Amarin Corporation plc shares, keeping their opinion on the stock as Underweight, with their previous recommendation back on May 06, 2022. While these analysts kept the previous recommendation, SVB Leerink raised their target price from $10 to $3. The new note on the price target was released on May 05, 2022, representing the official price target for Amarin Corporation plc stock. Previously, the target price had yet another drop from $10 to $3, while H.C. Wainwright kept a Neutral rating on AMRN stock.

The Average True Range (ATR) for Amarin Corporation plc is set at 0.09, with the Price to Sales ratio for AMRN stock in the period of the last 12 months amounting to 1.19. The Price to Book ratio for the last quarter was 0.90, with the Price to Cash per share for the same quarter was set at 0.79.

AMRN Stock Performance Analysis:

Amarin Corporation plc [AMRN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 6.50. With this latest performance, AMRN shares gained by 5.65% in over the last four-week period, additionally plugging by 3.15% over the last 6 months – not to mention a drop of -67.97% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AMRN stock in for the last two-week period is set at 59.07, with the RSI for the last a single of trading hit 63.46, and the three-weeks RSI is set at 55.54 for Amarin Corporation plc [AMRN]. The present Moving Average for the last 50 days of trading for this stock 1.1960, while it was recorded at 1.2400 for the last single week of trading, and 2.0406 for the last 200 days.

Insight into Amarin Corporation plc Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and Amarin Corporation plc [AMRN] shares currently have an operating margin of +4.15 and a Gross Margin at +78.71. Amarin Corporation plc’s Net Margin is presently recorded at +1.33.

Return on Equity for this stock inclined to 1.19, with Return on Assets sitting at 0.76.

Amarin Corporation plc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.60 and a Current Ratio set at 2.40.

AMRN Stock EPS

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AMRN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Amarin Corporation plc go to 38.90%.

Amarin Corporation plc [AMRN] Insider Position Details

There are presently around $180 million, or 35.30% of AMRN stock, in the hands of institutional investors. The top three institutional holders of AMRN stocks are: SARISSA CAPITAL MANAGEMENT LP with ownership of 23,998,000, which is approximately -0.008% of the company’s market cap and around 0.30% of the total institutional ownership; BAKER BROS. ADVISORS LP, holding 21,169,805 shares of the stock with an approximate value of $27.73 million in AMRN stocks shares; and EVERSEPT PARTNERS, LP, currently with $17.4 million in AMRN stock with ownership of nearly 47.936% of the company’s market capitalization.

Positions in Amarin Corporation plc stocks held by institutional investors increased at the end of October and at the time of the October reporting period, where 78 institutional holders increased their position in Amarin Corporation plc [NASDAQ:AMRN] by around 23,305,199 shares. Additionally, 87 investors decreased positions by around 15,074,807 shares, while 92 investors held positions by with 99,029,311 shares. The mentioned changes placed institutional holdings at 137,409,317 shares, according to the latest SEC report filing. AMRN stock had 32 new institutional investments in for a total of 5,599,122 shares, while 36 institutional investors sold positions of 7,621,504 shares during the same period.

LEAVE A REPLY

Please enter your comment!
Please enter your name here